To synthesize recent advancements in the molecular and cellular mechanisms governing immune-endothelial interactions and their implications in neurovascular pathology, emphasizing their significance for targeted therapeutic approaches.
Key Findings:
Cerebrovascular endothelium actively regulates neuroimmune responses, challenging the notion of the blood-brain barrier as a passive barrier, with implications for treatment strategies.
Activated endothelial cells interact with immune cells, leading to neuroinflammation and vascular dysfunction, highlighting potential therapeutic targets.
Aging exacerbates dysregulation in immune-endothelial interactions, contributing to neurological disease progression, necessitating age-specific interventions.
Recent technologies reveal heterogeneity in brain endothelial cells and their inflammatory signatures, suggesting personalized treatment approaches.
Interpretation:
Understanding immune-endothelial interactions is crucial for elucidating neurovascular pathophysiology and developing targeted therapeutic strategies that can effectively address these interactions.
Limitations:
Current reviews inadequately integrate recent technological advancements, limiting the understanding of immune-endothelial interactions.
Molecular mechanisms governing immune-endothelial interactions remain poorly understood, which may hinder the development of effective therapies.
Conclusion:
A comprehensive understanding of the immune-endothelial axis can inform precision diagnostic and therapeutic strategies for neurological disorders, underscoring the urgency of addressing the identified gaps.
